Interrupting signals exchanged between tumors and the nervous system could become a critical pillar of cancer care ...

In this part of his Pharmaceutical Executive video interview, Ian Chan, CEO of Abpro discusses the advantages of their DiversImmune and MultiMab platforms for antibody discovery and engineering.

The primary endpoint is objective response rate, with progression-free survival a key secondary endpoint. The study includes a pre-registration step for arm determination by the molecular tumor board.

Minnie Driver kicked off her Valentine’s Day festivities a bit early this year with a lovely tribute to her partner Addison O ...

Using a new technology and computational method, researchers from Fred Hutch Cancer Center and The University of Texas MD ...

Teddi Mellencamp's estranged husband Edwin Arroyave and their children visited the star shortly before she underwent emergency surgery after doctors found tumors on her brain.

Medicenna's financial statements for the three and nine months ended December 31, 2024, and the related management's discussion and analysis (MD&A) will be available on SEDAR+ at sedarplus.ca.

Patients with HRR-deficient metastatic castration-resistant prostate cancer experienced a 14-month gain in OS and a 38% lower ...

Pfizer hopes a unique life-extension benefit for its Talzenna can serve to further expand the drug’s already ...

Symphony Robotics said its goal is to reduce incision and craniotomy size to less than 4mm with its technology.

Real Housewives of Beverly Hills star Teddi Mellencamp, 43, was diagnosed 'multiple' brain tumors that may have been caused ...

Exelixis reported $515.2M in net product revenues in Q4'24, a 20% increase over net product revenues for Q4'23. See why I ...